Larry Anderson
Infectious Disease · Atlanta, GANPI 1336436799
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $296,449 of the $300,147 with a category attached, or 98.8%. Pfizer accounts for 93.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $228,838 and has fallen 100.0% since, to $41 in 2025. Among infectious disease clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $10,350 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$282K
- Janssen Scientific Affairs, LLC$10K
- AstraZeneca$5K
- Bavarian Nordic A/s$2K
- GSK$1K
- Amarin Pharma, Inc.$41
- plus $63 from 2 others
Across 5 payments — averaging $78,807 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$394K
What the payments were for
- Consulting fees$296,44999%
- Speaking & faculty fees$2,2751%
- Travel & lodging$1,0960%
- Food & beverage$3270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 12 | $281,773 |
| Janssen Scientific Affairs, LLC | 8 | $9,520 |
| AstraZeneca | 1 | $5,200 |
| Bavarian Nordic A/s | 1 | $2,250 |
| GSK | 1 | $1,300 |
| Amarin Pharma, Inc. | 3 | $41 |
| Seqirus USA Inc | 2 | $41 |
| Dermavant Sciences, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABRYSVO$203,526
How this compares
$300,147 in reported general payments places this provider in the 95th percentile of 260 infectious disease providers in Georgia.
Other infectious disease in Atlanta
- Zandraetta Tims-CookAtlanta$848K
- Quintin RobinsonAtlanta$270K
- James McMillenAtlanta$177K
- Leandro MenaAtlanta$141K
- Colleen KraftAtlanta$103K
- Walter OrensteinAtlanta$78K
- Nadine RouphaelAtlanta$66K
- Kimberly WorkowskiAtlanta$53K
- Bernard BransonAtlanta$36K
- Michelle JonesAtlanta$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.